CIBC World Market’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.81M Buy
76,709
+51,477
+204% +$4.12M 0.01% 567
2025
Q4
$2.41M Sell
25,232
-123,244
-83% -$12.1M ﹤0.01% 734
2025
Q3
$14.5M Sell
148,476
-7,818
-5% -$810K 0.03% 330
2025
Q2
$16.8M Sell
156,294
-459
-0.3% -$46.4K 0.03% 284
2025
Q1
$15.8M Buy
156,753
+144,921
+1,225% +$14.6M 0.03% 266
2024
Q4
$1.06M Sell
11,832
-239,733
-95% -$21.1M ﹤0.01% 863
2024
Q3
$21.1M Buy
251,565
+241,052
+2,293% +$19M 0.04% 221
2024
Q2
$810K Sell
10,513
-1,155
-10% -$84.5K ﹤0.01% 835
2024
Q1
$799K Sell
11,668
-39,463
-77% -$2.54M ﹤0.01% 861
2023
Q4
$2.96M Buy
51,131
+1,613
+3% +$86.1K 0.01% 515
2023
Q3
$2.62M Sell
49,518
-46,980
-49% -$2.46M 0.01% 510
2023
Q2
$5.22M Sell
96,498
-6,076
-6% -$317K 0.02% 376
2023
Q1
$5.13M Buy
102,574
+33,612
+49% +$1.58M 0.02% 366
2022
Q4
$3.19M Sell
68,962
-4,282
-6% -$185K 0.01% 462
2022
Q3
$2.84M Sell
73,244
-1,233
-2% -$49.5K 0.01% 471
2022
Q2
$2.78M Sell
74,477
-1,334
-2% -$54.3K 0.01% 468
2022
Q1
$3.36M Sell
75,811
-9,926
-12% -$430K 0.01% 462
2021
Q4
$3.64M Buy
85,737
+68,388
+394% +$2.87M 0.01% 463
2021
Q3
$753K Buy
17,349
+2,752
+19% +$122K ﹤0.01% 862
2021
Q2
$624K Sell
14,597
-34,645
-70% -$1.46M ﹤0.01% 927
2021
Q1
$1.9M Sell
49,242
-4,729
-9% -$179K 0.01% 597
2020
Q4
$1.94M Sell
53,971
-1,776
-3% -$64K 0.01% 575
2020
Q3
$2.13M Sell
55,747
-69,298
-55% -$2.67M 0.01% 486
2020
Q2
$4.39M Sell
125,045
-54,161
-30% -$1.95M 0.02% 315
2020
Q1
$5.85M Sell
179,206
-32,811
-15% -$1.28M 0.03% 224
2019
Q4
$9.59M Sell
212,017
-8,814
-4% -$369K 0.04% 212
2019
Q3
$8.99M Sell
220,831
-72,419
-25% -$3.07M 0.04% 199
2019
Q2
$12.6M Buy
293,250
+42,309
+17% +$1.63M 0.06% 160
2019
Q1
$9.63M Buy
250,941
+79,661
+47% +$3.04M 0.04% 194
2018
Q4
$6.05M Sell
171,280
-100,550
-37% -$3.65M 0.03% 235
2018
Q3
$10.5M Buy
271,830
+255,655
+1,581% +$8.93M 0.04% 181
2018
Q2
$529K Buy
16,175
+2,919
+22% +$88K ﹤0.01% 837
2018
Q1
$362K Buy
+13,256
New +$360K ﹤0.01% 941
2017
Q3
Sell
-23,913
Closed -$663K 803
2017
Q2
$663K Buy
+23,913
New +$635K ﹤0.01% 755
2017
Q1
Sell
-75,312
Closed -$1.63M 1006
2016
Q4
$1.63M Sell
75,312
-7,697
-9% -$168K 0.01% 482
2016
Q3
$1.98M Buy
+83,009
New +$1.98M 0.01% 362
2016
Q2
Sell
-13,300
Closed -$250K 930
2016
Q1
$250K Sell
13,300
-68,185
-84% -$1.2M ﹤0.01% 764
2015
Q4
$1.5M Buy
+81,485
New +$1.46M 0.01% 384
2015
Q3
Sell
-17,787
Closed -$315K 878
2015
Q2
$315K Sell
17,787
-3,335
-16% -$59.6K ﹤0.01% 760
2015
Q1
$375K Buy
+21,122
New +$334K ﹤0.01% 646
2014
Q2
Sell
-20,135
Closed -$272K 694
2014
Q1
$272K Buy
20,135
+4,882
+32% +$64.1K ﹤0.01% 642
2013
Q4
$183K Sell
15,253
-7,097
-32% -$83.8K ﹤0.01% 643
2013
Q3
$262K Sell
22,350
-15,740
-41% -$170K ﹤0.01% 562
2013
Q2
$353K Buy
+38,090
New +$323K ﹤0.01% 448

Other funds holding BSX

CIBC World Market's BSX Position: Q1 2026 in Review

CIBC World Market increased its Boston Scientific (BSX) stake by 204% in Q1 2026, buying an estimated $4.12M and bringing the position to 76,709 shares worth $4.81M. The position accounts for 0.01% of the portfolio, ranked #567.

CIBC World Market first reported a position in BSX in Q2 2013 and has held it in 44 quarters since. The position peaked at $21.1M in Q3 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • CIBC World Market held 76,709 shares of Boston Scientific worth $4.81M as of Q1 2026.
  • CIBC World Market bought 51,477 Boston Scientific shares in Q1 2026, an estimated $4.12M.
  • Boston Scientific made up 0.01% of CIBC World Market's portfolio in Q1 2026, its #567 holding.
  • CIBC World Market first reported a position in Boston Scientific in Q2 2013 and has held it in 44 quarters since.
  • CIBC World Market's Boston Scientific position peaked at $21.1M in Q3 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.